Date published: 2026-10-22

1-800-457-3801

SCBT Portrait Logo
Seach Input

Influenza A NP Antibody (F8): sc-52026

2.0(1)
Write a reviewAsk a question
Datasheets
  • Influenza A NP Antibody (F8) is a mouse monoclonal IgG2a, cited in 3 publications, provided at 100 µg/ml
  • raised against purified influenza virus type A strain H1N1
  • recommended for detection of nucleoprotein (NP) of Influenza A Virus origin by IF and ELISA
  • At present, we have not yet completed the identification of the preferred secondary detection reagent(s) for Influenza A NP Antibody (F8). This work is in progress.
Gene Editing Promo Banner

QUICK LINKS

SEE ALSO...

Influenza A NP Antibody (F8) is a mouse monoclonal IgG2a antibody that detects Influenza A NP by immunofluorescence (IF) and enzyme-linked immunosorbent assay (ELISA). Influenza A NP, or nucleoprotein, plays a crucial role in the viral life cycle, as it is essential for the encapsidation of the viral RNA genome and the formation of ribonucleoprotein complexes. This function is vital for the replication and transcription of the viral genome, making Influenza A NP a key target for antiviral strategies. Influenza A NP is located in the nucleus of infected cells, where Influenza A NP interacts with viral RNA and other proteins to facilitate the assembly of new virions. Understanding the dynamics of Influenza A NP is important for developing effective vaccines and therapeutics, as Influenza A NP can influence the pathogenicity and transmissibility of the virus. Anti-Influenza A NP antibody (F8) serves as an invaluable tool for researchers studying the mechanisms of Influenza A virus infection and the host immune response, providing insights that could lead to improved public health interventions.

For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.

Alexa Fluor® is a trademark of Molecular Probes Inc., OR., USA

LI-COR® and Odyssey® are registered trademarks of LI-COR Biosciences

Influenza A NP Antibody (F8) References:

  1. Influenza A virus reassortment.  |  Steel, J. and Lowen, AC. 2014. Curr Top Microbiol Immunol. 385: 377-401. PMID: 25007845
  2. The structure of the nucleoprotein of Influenza D shows that all Orthomyxoviridae nucleoproteins have a similar NPCORE, with or without a NPTAIL for nuclear transport.  |  Donchet, A., et al. 2019. Sci Rep. 9: 600. PMID: 30679709
  3. Emerging HxNy Influenza A Viruses.  |  Liu, WJ., et al. 2022. Cold Spring Harb Perspect Med. 12: PMID: 32928891
  4. Modeling the Influenza A NP-vRNA-Polymerase Complex in Atomic Detail.  |  Miner, JC., et al. 2021. Biomolecules. 11: PMID: 33477938
  5. Packaging signal of influenza A virus.  |  Li, X., et al. 2021. Virol J. 18: 36. PMID: 33596956
  6. The Continued Threat of Influenza A Viruses.  |  Roberts, NJ. and Krilov, LR. 2022. Viruses. 14: PMID: 35632626
  7. Influenza A Virus Neuraminidase Inhibitors.  |  Sriwilaijaroen, N., et al. 2022. Methods Mol Biol. 2556: 321-353. PMID: 36175642
  8. Influenza: A preventable infection in different populations.  |  Salvador García, C. and Gimeno Cardona, C. 2023. Enferm Infecc Microbiol Clin (Engl Ed). 41: 387-390. PMID: 37394402
  9. Fitness Determinants of Influenza A Viruses.  |  Griffin, EF. and Tompkins, SM. 2023. Viruses. 15: PMID: 37766365
  10. Influenza A Virus: Cellular Entry.  |  Miyake, Y., et al. 2023. Subcell Biochem. 106: 387-401. PMID: 38159235

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

Influenza A NP Antibody (F8)

sc-52026
100 µg/ml
$322.00